SlideShare a Scribd company logo
This presentation is compiled by “ Drug Regulations”
a non profit organization which provides free online
resource to the Pharmaceutical Professional.
Visit http://www.drugregulations.org for latest
information from the world of Pharmaceuticals.
11/17/2014 1
 This presentation is compiled from freely
available resource like the website of FDA.
“Drug Regulations” is a non profit
organization which provides free online
resource to the Pharmaceutical Professional.
 Visit http://www.drugregulations.org for
latest information from the world of
Pharmaceuticals.
11/17/2014 2
Drug Regulations : Online
Resource for Latest Information
◦ This presentation is part D of series of presentations which addresses the current Good
Manufacturing Requirements as per the US FDA.
◦ Part A : Status , Scope & Definitions
◦ Part B : Organization & Personnel
◦ Part C: Buildings & Facilities
◦ Part D : Equipment
◦ Part E : Control of Components , Drug Product Containers & Closures
◦ Part F : Production & Process Controls
◦ Part G : Packaging & Labeling Control
◦ Part H : Holding & Distribution
◦ Part I : Laboratory Controls
◦ Part J : Records & Reports
◦ Part K : Returned & Salvaged Products
11/17/2014 3
Drug Regulations : Online
Resource for Latest Information
 211.63
 Equipment∗ shall
◦ Be of appropriate design
◦ Be of adequate size
◦ Be suitably located
◦ Facilitate operations for its intended use
◦ Facilitate its cleaning and maintenance.
 ∗ used in the manufacture, processing, packing, or holding of a drug
product
11/17/2014 4
Drug Regulations : Online
Resource for Latest Information
 211.65 (a)
 Equipment∗ shall be constructed so that surfaces shall not
◦ Be reactive
◦ Be additive
◦ Be absorptive
 So as to alter the safety, identity, strength, quality, or
purity of the drug product beyond the official or other
established requirements.
 ∗ that contact components, in-process materials, or drug products
11/17/2014 5
Drug Regulations : Online
Resource for Latest Information
 211.65 (b)
 Substances such as lubricants or coolants shall not come into
contact with
◦ Components
◦ Drug product containers
◦ Closures
◦ In-process materials
◦ Drug products
◦ So as to alter the safety, identity, strength, quality, or purity of the drug
product beyond the official or other established requirements.
11/17/2014 6
Drug Regulations : Online
Resource for Latest Information
 211.67 (a)
 Clean & Maintain equipment and utensils
 Base this on the nature of the drug
 Sanitize and/or sterilize at appropriate intervals
◦ To prevent malfunctions or contamination
 That would alter the safety, identity, strength, quality, or
purity of the drug product beyond the official or other
established requirements.
11/17/2014 7
Drug Regulations : Online
Resource for Latest Information
 211.67 (b)
 Establish written procedures for
◦ Equipment∗ cleaning
◦ Equipment ∗ maintenance
◦ Utensils ∗ cleaning
 Follow written procedures
 ∗ used in the manufacture, processing, packing, or holding
of a drug product.
11/17/2014 8
Drug Regulations : Online
Resource for Latest Information
 211.67 (b)
 Include at least following in the procedure to Assure
proper cleaning and maintenance
◦ (1) Assignment of responsibility for cleaning and
maintaining equipment;
◦ (2) Maintenance and cleaning schedules, sanitizing
schedules;
11/17/2014 9
Drug Regulations : Online
Resource for Latest Information
 211.67 (b) (3)
 Include at least following in the procedure to Assure
proper cleaning and maintenance
◦ Detailed cleaning Methods
◦ Equipment used for cleaning
◦ Materials used for cleaning
◦ Methods of disassembling process equipment
◦ Methods of reassembling process equipment
11/17/2014 10
Drug Regulations : Online
Resource for Latest Information
 211.67 (b)
 Include at least following in the procedure to Assure
proper cleaning and maintenance
 (4) Removal or obliteration of previous batch identification;
 (5) Protection of clean equipment from contamination prior to
use;
 (6) Inspection of equipment for cleanliness immediately before
use.
11/17/2014 11
Drug Regulations : Online
Resource for Latest Information
 211.67 (c)
 Maintain records of : (§§211.180 and 211.182.)
 Maintenance
 Cleaning
 Sanitizing
 Inspection
11/17/2014 12
Drug Regulations : Online
Resource for Latest Information
 211.68 (a)
 Following equipment which will perform satisfactorily
can be used in manufacture
 Automatic Equipment
 Mechanical Equipment
 Electronic Equipment
 Other types of Equipment
 Computers, or related systems
11/17/2014 13
Drug Regulations : Online
Resource for Latest Information
 211.68 (a)
 If such equipment is used perform routinely
 Calibrations
 Inspections
 Check to assure proper performance
 Maintain written records of calibration checks and
inspections
11/17/2014 14
Drug Regulations : Online
Resource for Latest Information
 211.68 (b)
 Ensure appropriate controls
 Ensure that only authorized personnel make changes in
master production and control records
 Check input to and output from the computer for
accuracy.
 Base the frequency of input/output verification on the
complexity and reliability of the computer system.
11/17/2014 15
Drug Regulations : Online
Resource for Latest Information
 211.68 (b)
 Maintain a backup file of data entered into the
computer or related system
 Exception
 Where certain data, such as calculations performed in
connection with laboratory analysis, are eliminated by
computerization or other automated processes.
11/17/2014 16
Drug Regulations : Online
Resource for Latest Information
 211.68 (b)
 In such instances maintain a written record of the
program along with appropriate validation data
11/17/2014 17
Drug Regulations : Online
Resource for Latest Information
 211.68 (b)
 Maintain hard copy or alternative systems,
 Duplicates
 Tapes
 Microfilm
11/17/2014 18
Drug Regulations : Online
Resource for Latest Information
 211.68 (b)
 Ensure that backup data are
 Exact
 Secure from
 Alteration
 Inadvertent erasures
 Loss
11/17/2014 19
Drug Regulations : Online
Resource for Latest Information
 211.68 (c)
 GMP’s require performance of operation by one person &
checking by another. §§211.101(c) or (d), 211.103, 211.182, or
211.188(b)(11)
 Automated equipment can meet these requirements if
 The equipment is used in conformity with this section and
 One person checks that the equipment properly performed the
operation
11/17/2014 20
Drug Regulations : Online
Resource for Latest Information
 211.72 (c)
 Ensure that filters∗ for liquid filtration do not release
fibers into such products.
 Fiber-releasing filters may be used when it is not
possible to manufacture such products without the
use of these filters.
11/17/2014 21
Drug Regulations : Online
Resource for Latest Information
 211.72 (c)
 If such fibres are used
 Use an additional nonfiber-releasing filter having a maximum
nominal pore size rating of 0.2 micron (0.45 micron if the
manufacturing conditions so dictate) to reduce the content of
particles in the injectable drug product.
 The use of an asbestos-containing filter is prohibited.
 ∗ used in the manufacture, processing, or packing of injectable
drug products intended for human use
11/17/2014 22
Drug Regulations : Online
Resource for Latest Information
 This presentation is compiled from freely
available resource like the website of FDA.
“Drug Regulations” is a non profit
organization which provides free online
resource to the Pharmaceutical Professional.
 Visit http://www.drugregulations.org for
latest information from the world of
Pharmaceuticals.
11/17/2014 23
Drug Regulations : Online
Resource for Latest Information

More Related Content

What's hot

US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
GMP EDUCATION : Not for Profit Organization
 
FDA Guidance on Facing Manufacturing Inspections
FDA Guidance on Facing Manufacturing InspectionsFDA Guidance on Facing Manufacturing Inspections
FDA Guidance on Facing Manufacturing Inspections
GMP EDUCATION : Not for Profit Organization
 
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
GMP EDUCATION : Not for Profit Organization
 
New Draft FDA Guidance on Analytical Method Development & Validations.
New Draft FDA Guidance on Analytical Method Development & Validations.New Draft FDA Guidance on Analytical Method Development & Validations.
New Draft FDA Guidance on Analytical Method Development & Validations.
GMP EDUCATION : Not for Profit Organization
 
MHRA Data Integrity Requirements
MHRA Data Integrity RequirementsMHRA Data Integrity Requirements
MHRA Data Integrity Requirements
GMP EDUCATION : Not for Profit Organization
 
Good Practices for Computerised Systems : PIC/S Guidance
Good Practices for Computerised Systems : PIC/S GuidanceGood Practices for Computerised Systems : PIC/S Guidance
Good Practices for Computerised Systems : PIC/S Guidance
GMP EDUCATION : Not for Profit Organization
 
New gdp's for medicinal products
New gdp's for medicinal productsNew gdp's for medicinal products
New gdp's for medicinal products
GMP EDUCATION : Not for Profit Organization
 
New WHO Guidance on Process Validation
New WHO Guidance on Process ValidationNew WHO Guidance on Process Validation
New WHO Guidance on Process Validation
GMP EDUCATION : Not for Profit Organization
 
Who Guidelines for Preparing SMF
Who Guidelines for Preparing  SMFWho Guidelines for Preparing  SMF
Who Guidelines for Preparing SMF
GMP EDUCATION : Not for Profit Organization
 
Process Validation of Legacy Products
Process Validation of Legacy ProductsProcess Validation of Legacy Products
Process Validation of Legacy Products
GMP EDUCATION : Not for Profit Organization
 
New EU Serialisation / Track & Trace Requirements.
New EU Serialisation / Track & Trace Requirements.  New EU Serialisation / Track & Trace Requirements.
New EU Serialisation / Track & Trace Requirements.
GMP EDUCATION : Not for Profit Organization
 
Complaints , quality defects & recalls - New EMA Requirements
 Complaints , quality defects & recalls - New EMA Requirements Complaints , quality defects & recalls - New EMA Requirements
Complaints , quality defects & recalls - New EMA Requirements
GMP EDUCATION : Not for Profit Organization
 
Presentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QPPresentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QP
GMP EDUCATION : Not for Profit Organization
 
WHO Guidance on Preparation of Laboratory Information File
WHO  Guidance on Preparation of Laboratory Information FileWHO  Guidance on Preparation of Laboratory Information File
WHO Guidance on Preparation of Laboratory Information File
GMP EDUCATION : Not for Profit Organization
 
Presentation on US FDA Data Integrity Guidance.
Presentation on US FDA  Data Integrity Guidance.Presentation on US FDA  Data Integrity Guidance.
Presentation on US FDA Data Integrity Guidance.
GMP EDUCATION : Not for Profit Organization
 
New WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method ValidationNew WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method Validation
GMP EDUCATION : Not for Profit Organization
 
US FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process VerificationUS FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process Verification
GMP EDUCATION : Not for Profit Organization
 
Quality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental MonitoringQuality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental Monitoring
GMP EDUCATION : Not for Profit Organization
 
US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...
US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...
US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...GMP EDUCATION : Not for Profit Organization
 
New EU Requirements for Qualification & Validation
New EU Requirements for Qualification & ValidationNew EU Requirements for Qualification & Validation
New EU Requirements for Qualification & Validation
GMP EDUCATION : Not for Profit Organization
 

What's hot (20)

US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
 
FDA Guidance on Facing Manufacturing Inspections
FDA Guidance on Facing Manufacturing InspectionsFDA Guidance on Facing Manufacturing Inspections
FDA Guidance on Facing Manufacturing Inspections
 
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
 
New Draft FDA Guidance on Analytical Method Development & Validations.
New Draft FDA Guidance on Analytical Method Development & Validations.New Draft FDA Guidance on Analytical Method Development & Validations.
New Draft FDA Guidance on Analytical Method Development & Validations.
 
MHRA Data Integrity Requirements
MHRA Data Integrity RequirementsMHRA Data Integrity Requirements
MHRA Data Integrity Requirements
 
Good Practices for Computerised Systems : PIC/S Guidance
Good Practices for Computerised Systems : PIC/S GuidanceGood Practices for Computerised Systems : PIC/S Guidance
Good Practices for Computerised Systems : PIC/S Guidance
 
New gdp's for medicinal products
New gdp's for medicinal productsNew gdp's for medicinal products
New gdp's for medicinal products
 
New WHO Guidance on Process Validation
New WHO Guidance on Process ValidationNew WHO Guidance on Process Validation
New WHO Guidance on Process Validation
 
Who Guidelines for Preparing SMF
Who Guidelines for Preparing  SMFWho Guidelines for Preparing  SMF
Who Guidelines for Preparing SMF
 
Process Validation of Legacy Products
Process Validation of Legacy ProductsProcess Validation of Legacy Products
Process Validation of Legacy Products
 
New EU Serialisation / Track & Trace Requirements.
New EU Serialisation / Track & Trace Requirements.  New EU Serialisation / Track & Trace Requirements.
New EU Serialisation / Track & Trace Requirements.
 
Complaints , quality defects & recalls - New EMA Requirements
 Complaints , quality defects & recalls - New EMA Requirements Complaints , quality defects & recalls - New EMA Requirements
Complaints , quality defects & recalls - New EMA Requirements
 
Presentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QPPresentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QP
 
WHO Guidance on Preparation of Laboratory Information File
WHO  Guidance on Preparation of Laboratory Information FileWHO  Guidance on Preparation of Laboratory Information File
WHO Guidance on Preparation of Laboratory Information File
 
Presentation on US FDA Data Integrity Guidance.
Presentation on US FDA  Data Integrity Guidance.Presentation on US FDA  Data Integrity Guidance.
Presentation on US FDA Data Integrity Guidance.
 
New WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method ValidationNew WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method Validation
 
US FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process VerificationUS FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process Verification
 
Quality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental MonitoringQuality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental Monitoring
 
US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...
US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...
US FDA Process Validation Stage 2 : No. Of Batches Required for Process Perfo...
 
New EU Requirements for Qualification & Validation
New EU Requirements for Qualification & ValidationNew EU Requirements for Qualification & Validation
New EU Requirements for Qualification & Validation
 

Viewers also liked

Training in cGMP Environment for Begninners
Training in cGMP Environment for BegninnersTraining in cGMP Environment for Begninners
Training in cGMP Environment for Begninners
GMP EDUCATION : Not for Profit Organization
 
Product quality review
Product quality reviewProduct quality review
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...Atlantic Training, LLC.
 
Current Good Manufacturing Practices by WSFCS
Current Good Manufacturing Practices by WSFCSCurrent Good Manufacturing Practices by WSFCS
Current Good Manufacturing Practices by WSFCS
Atlantic Training, LLC.
 
Introduction to Food Safety Management and GMP by FAO
Introduction to Food Safety Management and GMP by FAOIntroduction to Food Safety Management and GMP by FAO
Introduction to Food Safety Management and GMP by FAO
Atlantic Training, LLC.
 
Good Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety ConsultancyGood Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety ConsultancyAtlantic Training, LLC.
 
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas AndalasGMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas AndalasAtlantic Training, LLC.
 
Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...
Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...
Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...Atlantic Training, LLC.
 

Viewers also liked (9)

Training in cGMP Environment for Begninners
Training in cGMP Environment for BegninnersTraining in cGMP Environment for Begninners
Training in cGMP Environment for Begninners
 
Product quality review
Product quality reviewProduct quality review
Product quality review
 
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
 
Current Good Manufacturing Practices by WSFCS
Current Good Manufacturing Practices by WSFCSCurrent Good Manufacturing Practices by WSFCS
Current Good Manufacturing Practices by WSFCS
 
Introduction to Food Safety Management and GMP by FAO
Introduction to Food Safety Management and GMP by FAOIntroduction to Food Safety Management and GMP by FAO
Introduction to Food Safety Management and GMP by FAO
 
cGMP in the USA Training by CDER FDA
cGMP in the USA Training by CDER FDAcGMP in the USA Training by CDER FDA
cGMP in the USA Training by CDER FDA
 
Good Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety ConsultancyGood Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety Consultancy
 
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas AndalasGMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
 
Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...
Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...
Good Manufacturing Practice (“GMP”) Compliance: GMPs EXPLAINED by SIDLEY AUST...
 

Similar to GMP's as per US FDA : Part D

GMP's as per US FDA
GMP's as per US FDA GMP's as per US FDA
Comparision of US & Indian GMP's
Comparision of US & Indian GMP'sComparision of US & Indian GMP's
Comparision of US & Indian GMP's
GMP EDUCATION : Not for Profit Organization
 
US FDA GMP Part J & Part K
US FDA GMP Part J  & Part K US FDA GMP Part J  & Part K
US FDA GMP Part J & Part K
GMP EDUCATION : Not for Profit Organization
 
Computer System Validation
Computer System ValidationComputer System Validation
21 CFR Part 211.pptx
21 CFR Part 211.pptx21 CFR Part 211.pptx
21 CFR Part 211.pptx
rautrahul8080
 
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Rx Research Services CRO
 
FDA Guidance on Facing Sterile Manufacturing Inspections.
FDA Guidance on Facing Sterile Manufacturing  Inspections.FDA Guidance on Facing Sterile Manufacturing  Inspections.
FDA Guidance on Facing Sterile Manufacturing Inspections.
GMP EDUCATION : Not for Profit Organization
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
SathiyaThaarani
 
Current good manufacturing practice
Current good manufacturing practiceCurrent good manufacturing practice
Current good manufacturing practice
Dr Subodh Satheesh
 
Current Good Manufacturing Practices
Current Good Manufacturing PracticesCurrent Good Manufacturing Practices
Current Good Manufacturing Practices
Swapnil Fernandes
 
Data integrity
Data integrityData integrity
Data integrity
Mohamed Anvar Deen
 
processing of in-process & bulk product.pptx
processing of in-process & bulk product.pptxprocessing of in-process & bulk product.pptx
processing of in-process & bulk product.pptx
laxmidharsahoo7
 
21 CFR CGMP
21 CFR  CGMP21 CFR  CGMP
21 CFR CGMP
ssuserf14ecf
 
Data Integrity in FDA Regulated Labs
Data Integrity in FDA Regulated LabsData Integrity in FDA Regulated Labs
Data Integrity in FDA Regulated Labs
GMP EDUCATION : Not for Profit Organization
 
EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements
GMP EDUCATION : Not for Profit Organization
 
GMP in Pharmaceutical Industry by Dr.A S Charan
GMP in Pharmaceutical Industry by Dr.A S CharanGMP in Pharmaceutical Industry by Dr.A S Charan
GMP in Pharmaceutical Industry by Dr.A S Charan
Charan Archakam
 
cGMP's for sterile products
cGMP's  for sterile productscGMP's  for sterile products
cGMP's for sterile products
GMP EDUCATION : Not for Profit Organization
 
ICH Q7 GMP for API
ICH Q7 GMP for APIICH Q7 GMP for API
ICH Q7 GMP for API
prashik shimpi
 
New EMA Requirements for Excipient GMP's
New EMA Requirements for  Excipient GMP'sNew EMA Requirements for  Excipient GMP's
New EMA Requirements for Excipient GMP's
GMP EDUCATION : Not for Profit Organization
 
Qb d agency expectations
Qb d agency expectationsQb d agency expectations

Similar to GMP's as per US FDA : Part D (20)

GMP's as per US FDA
GMP's as per US FDA GMP's as per US FDA
GMP's as per US FDA
 
Comparision of US & Indian GMP's
Comparision of US & Indian GMP'sComparision of US & Indian GMP's
Comparision of US & Indian GMP's
 
US FDA GMP Part J & Part K
US FDA GMP Part J  & Part K US FDA GMP Part J  & Part K
US FDA GMP Part J & Part K
 
Computer System Validation
Computer System ValidationComputer System Validation
Computer System Validation
 
21 CFR Part 211.pptx
21 CFR Part 211.pptx21 CFR Part 211.pptx
21 CFR Part 211.pptx
 
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
Marlene Garcia Swider ASQ, PDA, SoCalBio Presentation Oct. 6
 
FDA Guidance on Facing Sterile Manufacturing Inspections.
FDA Guidance on Facing Sterile Manufacturing  Inspections.FDA Guidance on Facing Sterile Manufacturing  Inspections.
FDA Guidance on Facing Sterile Manufacturing Inspections.
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
 
Current good manufacturing practice
Current good manufacturing practiceCurrent good manufacturing practice
Current good manufacturing practice
 
Current Good Manufacturing Practices
Current Good Manufacturing PracticesCurrent Good Manufacturing Practices
Current Good Manufacturing Practices
 
Data integrity
Data integrityData integrity
Data integrity
 
processing of in-process & bulk product.pptx
processing of in-process & bulk product.pptxprocessing of in-process & bulk product.pptx
processing of in-process & bulk product.pptx
 
21 CFR CGMP
21 CFR  CGMP21 CFR  CGMP
21 CFR CGMP
 
Data Integrity in FDA Regulated Labs
Data Integrity in FDA Regulated LabsData Integrity in FDA Regulated Labs
Data Integrity in FDA Regulated Labs
 
EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements
 
GMP in Pharmaceutical Industry by Dr.A S Charan
GMP in Pharmaceutical Industry by Dr.A S CharanGMP in Pharmaceutical Industry by Dr.A S Charan
GMP in Pharmaceutical Industry by Dr.A S Charan
 
cGMP's for sterile products
cGMP's  for sterile productscGMP's  for sterile products
cGMP's for sterile products
 
ICH Q7 GMP for API
ICH Q7 GMP for APIICH Q7 GMP for API
ICH Q7 GMP for API
 
New EMA Requirements for Excipient GMP's
New EMA Requirements for  Excipient GMP'sNew EMA Requirements for  Excipient GMP's
New EMA Requirements for Excipient GMP's
 
Qb d agency expectations
Qb d agency expectationsQb d agency expectations
Qb d agency expectations
 

More from GMP EDUCATION : Not for Profit Organization

Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
GMP EDUCATION : Not for Profit Organization
 
Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
GMP EDUCATION : Not for Profit Organization
 
Blend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way ForwardBlend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way Forward
GMP EDUCATION : Not for Profit Organization
 
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
GMP EDUCATION : Not for Profit Organization
 
Calculation of Risk Priority Numbar
Calculation of  Risk Priority NumbarCalculation of  Risk Priority Numbar
Calculation of Risk Priority Numbar
GMP EDUCATION : Not for Profit Organization
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
GMP EDUCATION : Not for Profit Organization
 
New WHO Guidance on CS Validation
New WHO Guidance on CS ValidationNew WHO Guidance on CS Validation
New WHO Guidance on CS Validation
GMP EDUCATION : Not for Profit Organization
 
ASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and QualificationsASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and Qualifications
GMP EDUCATION : Not for Profit Organization
 
US FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ BatchesUS FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ Batches
GMP EDUCATION : Not for Profit Organization
 
Understanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room ContaminationUnderstanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room Contamination
GMP EDUCATION : Not for Profit Organization
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
GMP EDUCATION : Not for Profit Organization
 
Validation of Microbiological Methods
Validation of Microbiological MethodsValidation of Microbiological Methods
Validation of Microbiological Methods
GMP EDUCATION : Not for Profit Organization
 
WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.
GMP EDUCATION : Not for Profit Organization
 
Who Guidance on Quality Risk Management
Who Guidance on Quality Risk ManagementWho Guidance on Quality Risk Management
Who Guidance on Quality Risk Management
GMP EDUCATION : Not for Profit Organization
 
Water for Pharmaceutical Purposes - New USP Requriements
Water for Pharmaceutical Purposes - New USP  RequriementsWater for Pharmaceutical Purposes - New USP  Requriements
Water for Pharmaceutical Purposes - New USP Requriements
GMP EDUCATION : Not for Profit Organization
 
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
WHO Guidance on HVAC  Systems for Non Sterile PharmaceuticalsWHO Guidance on HVAC  Systems for Non Sterile Pharmaceuticals
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
GMP EDUCATION : Not for Profit Organization
 
Handling of Out of Specification Results
Handling of Out of Specification ResultsHandling of Out of Specification Results
Handling of Out of Specification Results
GMP EDUCATION : Not for Profit Organization
 
Presentation on EU Regulatory & Quality System.
Presentation on EU Regulatory & Quality System.Presentation on EU Regulatory & Quality System.
Presentation on EU Regulatory & Quality System.
GMP EDUCATION : Not for Profit Organization
 

More from GMP EDUCATION : Not for Profit Organization (18)

Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
 
Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
 
Blend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way ForwardBlend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way Forward
 
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
 
Calculation of Risk Priority Numbar
Calculation of  Risk Priority NumbarCalculation of  Risk Priority Numbar
Calculation of Risk Priority Numbar
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
 
New WHO Guidance on CS Validation
New WHO Guidance on CS ValidationNew WHO Guidance on CS Validation
New WHO Guidance on CS Validation
 
ASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and QualificationsASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and Qualifications
 
US FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ BatchesUS FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ Batches
 
Understanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room ContaminationUnderstanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room Contamination
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
 
Validation of Microbiological Methods
Validation of Microbiological MethodsValidation of Microbiological Methods
Validation of Microbiological Methods
 
WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.
 
Who Guidance on Quality Risk Management
Who Guidance on Quality Risk ManagementWho Guidance on Quality Risk Management
Who Guidance on Quality Risk Management
 
Water for Pharmaceutical Purposes - New USP Requriements
Water for Pharmaceutical Purposes - New USP  RequriementsWater for Pharmaceutical Purposes - New USP  Requriements
Water for Pharmaceutical Purposes - New USP Requriements
 
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
WHO Guidance on HVAC  Systems for Non Sterile PharmaceuticalsWHO Guidance on HVAC  Systems for Non Sterile Pharmaceuticals
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
 
Handling of Out of Specification Results
Handling of Out of Specification ResultsHandling of Out of Specification Results
Handling of Out of Specification Results
 
Presentation on EU Regulatory & Quality System.
Presentation on EU Regulatory & Quality System.Presentation on EU Regulatory & Quality System.
Presentation on EU Regulatory & Quality System.
 

Recently uploaded

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 

Recently uploaded (20)

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 

GMP's as per US FDA : Part D

  • 1. This presentation is compiled by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional. Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. 11/17/2014 1
  • 2.  This presentation is compiled from freely available resource like the website of FDA. “Drug Regulations” is a non profit organization which provides free online resource to the Pharmaceutical Professional.  Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. 11/17/2014 2 Drug Regulations : Online Resource for Latest Information
  • 3. ◦ This presentation is part D of series of presentations which addresses the current Good Manufacturing Requirements as per the US FDA. ◦ Part A : Status , Scope & Definitions ◦ Part B : Organization & Personnel ◦ Part C: Buildings & Facilities ◦ Part D : Equipment ◦ Part E : Control of Components , Drug Product Containers & Closures ◦ Part F : Production & Process Controls ◦ Part G : Packaging & Labeling Control ◦ Part H : Holding & Distribution ◦ Part I : Laboratory Controls ◦ Part J : Records & Reports ◦ Part K : Returned & Salvaged Products 11/17/2014 3 Drug Regulations : Online Resource for Latest Information
  • 4.  211.63  Equipment∗ shall ◦ Be of appropriate design ◦ Be of adequate size ◦ Be suitably located ◦ Facilitate operations for its intended use ◦ Facilitate its cleaning and maintenance.  ∗ used in the manufacture, processing, packing, or holding of a drug product 11/17/2014 4 Drug Regulations : Online Resource for Latest Information
  • 5.  211.65 (a)  Equipment∗ shall be constructed so that surfaces shall not ◦ Be reactive ◦ Be additive ◦ Be absorptive  So as to alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements.  ∗ that contact components, in-process materials, or drug products 11/17/2014 5 Drug Regulations : Online Resource for Latest Information
  • 6.  211.65 (b)  Substances such as lubricants or coolants shall not come into contact with ◦ Components ◦ Drug product containers ◦ Closures ◦ In-process materials ◦ Drug products ◦ So as to alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements. 11/17/2014 6 Drug Regulations : Online Resource for Latest Information
  • 7.  211.67 (a)  Clean & Maintain equipment and utensils  Base this on the nature of the drug  Sanitize and/or sterilize at appropriate intervals ◦ To prevent malfunctions or contamination  That would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements. 11/17/2014 7 Drug Regulations : Online Resource for Latest Information
  • 8.  211.67 (b)  Establish written procedures for ◦ Equipment∗ cleaning ◦ Equipment ∗ maintenance ◦ Utensils ∗ cleaning  Follow written procedures  ∗ used in the manufacture, processing, packing, or holding of a drug product. 11/17/2014 8 Drug Regulations : Online Resource for Latest Information
  • 9.  211.67 (b)  Include at least following in the procedure to Assure proper cleaning and maintenance ◦ (1) Assignment of responsibility for cleaning and maintaining equipment; ◦ (2) Maintenance and cleaning schedules, sanitizing schedules; 11/17/2014 9 Drug Regulations : Online Resource for Latest Information
  • 10.  211.67 (b) (3)  Include at least following in the procedure to Assure proper cleaning and maintenance ◦ Detailed cleaning Methods ◦ Equipment used for cleaning ◦ Materials used for cleaning ◦ Methods of disassembling process equipment ◦ Methods of reassembling process equipment 11/17/2014 10 Drug Regulations : Online Resource for Latest Information
  • 11.  211.67 (b)  Include at least following in the procedure to Assure proper cleaning and maintenance  (4) Removal or obliteration of previous batch identification;  (5) Protection of clean equipment from contamination prior to use;  (6) Inspection of equipment for cleanliness immediately before use. 11/17/2014 11 Drug Regulations : Online Resource for Latest Information
  • 12.  211.67 (c)  Maintain records of : (§§211.180 and 211.182.)  Maintenance  Cleaning  Sanitizing  Inspection 11/17/2014 12 Drug Regulations : Online Resource for Latest Information
  • 13.  211.68 (a)  Following equipment which will perform satisfactorily can be used in manufacture  Automatic Equipment  Mechanical Equipment  Electronic Equipment  Other types of Equipment  Computers, or related systems 11/17/2014 13 Drug Regulations : Online Resource for Latest Information
  • 14.  211.68 (a)  If such equipment is used perform routinely  Calibrations  Inspections  Check to assure proper performance  Maintain written records of calibration checks and inspections 11/17/2014 14 Drug Regulations : Online Resource for Latest Information
  • 15.  211.68 (b)  Ensure appropriate controls  Ensure that only authorized personnel make changes in master production and control records  Check input to and output from the computer for accuracy.  Base the frequency of input/output verification on the complexity and reliability of the computer system. 11/17/2014 15 Drug Regulations : Online Resource for Latest Information
  • 16.  211.68 (b)  Maintain a backup file of data entered into the computer or related system  Exception  Where certain data, such as calculations performed in connection with laboratory analysis, are eliminated by computerization or other automated processes. 11/17/2014 16 Drug Regulations : Online Resource for Latest Information
  • 17.  211.68 (b)  In such instances maintain a written record of the program along with appropriate validation data 11/17/2014 17 Drug Regulations : Online Resource for Latest Information
  • 18.  211.68 (b)  Maintain hard copy or alternative systems,  Duplicates  Tapes  Microfilm 11/17/2014 18 Drug Regulations : Online Resource for Latest Information
  • 19.  211.68 (b)  Ensure that backup data are  Exact  Secure from  Alteration  Inadvertent erasures  Loss 11/17/2014 19 Drug Regulations : Online Resource for Latest Information
  • 20.  211.68 (c)  GMP’s require performance of operation by one person & checking by another. §§211.101(c) or (d), 211.103, 211.182, or 211.188(b)(11)  Automated equipment can meet these requirements if  The equipment is used in conformity with this section and  One person checks that the equipment properly performed the operation 11/17/2014 20 Drug Regulations : Online Resource for Latest Information
  • 21.  211.72 (c)  Ensure that filters∗ for liquid filtration do not release fibers into such products.  Fiber-releasing filters may be used when it is not possible to manufacture such products without the use of these filters. 11/17/2014 21 Drug Regulations : Online Resource for Latest Information
  • 22.  211.72 (c)  If such fibres are used  Use an additional nonfiber-releasing filter having a maximum nominal pore size rating of 0.2 micron (0.45 micron if the manufacturing conditions so dictate) to reduce the content of particles in the injectable drug product.  The use of an asbestos-containing filter is prohibited.  ∗ used in the manufacture, processing, or packing of injectable drug products intended for human use 11/17/2014 22 Drug Regulations : Online Resource for Latest Information
  • 23.  This presentation is compiled from freely available resource like the website of FDA. “Drug Regulations” is a non profit organization which provides free online resource to the Pharmaceutical Professional.  Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. 11/17/2014 23 Drug Regulations : Online Resource for Latest Information